Substituted pyrimidyl guanidine derivatives having anticancer activity

摘要

Disclosed are pyrimidyl guanidine derivatives having anticancer activity. The pyimidyl guanidine derivatives have the structure:; R₁ is a cyclic (1-7 member) or acyclic (1-7 member) aliphatic, aromatic, heterocyclic groups optionally substituted, R₂ is a cyclic (3-7 member) aliphatic, aromatic, heterocyclic groups optionally substituted by functional groups and R₃ is a cyclic (3-7 member) aliphatic, aromatic, heterocyclic groups.